Advisory Board

The LSM advisory board is designed to bring together industry leaders, scientific and medical experts, and corporate executives who can provide guidance and feedback on both curricular and co-curricular aspects of the program.

Current members of the advisory board are:

Ron Belldegrun 

CEO, Co-Founder

Joan Lau, Ph.D.

(ENG'92, WG'08) 
Co-Founder and CEO
Militia Hill Ventures

Robert Benz, M.D.

(C'74, PAR'05, PAR'06)
Vice President of Medical Affairs
Lankenau Medical Center
Chief of Nephrology
Main Line Health Hospital


Ameet Mallik

President and CEO
ADC Therapeutics

Laura Bessen, M.D.

Vice President, Head of U.S. Medical (retired)
Bristol-Myers Squibb

Vijai Mohan

(C'98, GR'99)
Founder and CEO
Secure Transfusion Solutions, Inc

David Blumberg

(WG'90): Advisory Board Chair
Retired Principal and Advisory Sector Leader - Pharmaceuticals 
VP Global Commercial Compliance - 
Teva Pharmaceuticals

Steven Nichtberger, M.D.

(C'83, W'83)
Chairman, CEO, Co-Founder
Cabaletta Bio

Ellen Davis

(W'85, PAR'13) Member, Board of Overseers 
Weill Cornell Medicine
Member, Board of Overseers 
Melanoma Research Alliance

Paul Offit, M.D.

Chief of Infectious Diseases
Children’s Hospital of Philadelphia


Garret FitzGerald, M.D.

Professor of Medicine and Chair, Department of Pharmacology
University of Pennsylvania

Phil Ross, M.D.

Vice Chairman, Healthcare Investment Banking
J.P. Morgan

David Gluckman, M.D.

Vice Chairman of Investment Banking
Global Head of Healthcare
Lazard, LLC

Lee Schalop, M.D

(C'85, W'85)
Biotech Industry Angel Investor and Entrepreneur

Henry Gosebruch

Executive Vice President and Chief Strategy Officer
AbbVie, Inc.

Barbara Schilberg, J.D.

Managing Director & Chief Executive Officer (retired)

Keith Gottesdiener, M.D.

President & CEO
Prime Medicine, Inc

Lisa Schoenberg

Vice President, Sales & Marketing (retired)

Evis Hursever, Ph.D.

Managing Director
EW Healthcare Partners

Sheri Schully, Ph.D.

Deputy Chief Medical and Scientific Officer, All of Us Research Program
National Institutes of Health

Najat Khan, Ph.D.

Chief Data Science Officer, Global Head, Strategy & Operations
Janssen Research & Development

Martin Silverstein, M.D.

(C'76, PAR'11)
President and CEO
Mana Therapeutics

Lorence Kim, M.D.

(MED'99, WG'99)
Venture Partner
Third Rock Ventures

Richard L. Solit, M.D.

Portfolio Manager
Adage Capital Management

Brian Kim

(C'93, W'93)
Founder, CEO, Executive Director
Fortis Life Sciences

Kuo Tong

Guidehouse/ Navigant Consulting

Adam Koppel, M.D. Ph.D.

(MED'95, GR'97, WG'00)
Managing Director, Biosciences
Bain Capital

P. Roy Vagelos, M.D. 

(C'50) - honorary member
Chairman of the Board
Regeneron Pharmaceuticals, Inc.
Retired Chair of the Board and Chief Executive Officer



Alumni members of the advisory board are:

Pia Banerjee


Executive Director, 

Head of Investor Relations and Strategy

Arcus Biosciences

Nicholas Wilcox, M.D.


Resident Physician, Internal Medicine

Penn Medicine